NasdaqGS - Nasdaq Real Time Price USD
Crinetics Pharmaceuticals, Inc. (CRNX)
31.88
+1.37
+(4.49%)
At close: June 2 at 4:00:01 PM EDT
31.88
0.00
(0.00%)
After hours: June 2 at 4:55:16 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-261,566
-225,970
-166,307
-115,205
-88,588
Investing Cash Flow
-661,087
-574,817
-200,413
-173,980
-56,483
Financing Cash Flow
621,298
1,010,435
388,944
121,963
252,679
End Cash Position
95,869
265,845
56,197
33,973
201,195
Interest Paid Supplemental Data
0
--
--
--
--
Capital Expenditure
-3,751
-3,844
-4,688
-1,656
-436
Issuance of Capital Stock
586,833
970,048
369,019
117,242
249,542
Repayment of Debt
0
--
--
--
--
Repurchase of Capital Stock
--
--
--
--
0
Free Cash Flow
-265,317
-229,814
-170,995
-116,861
-89,024
12/31/2021 - 7/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDYA IDEAYA Biosciences, Inc.
21.22
+6.69%
XENE Xenon Pharmaceuticals Inc.
30.07
+4.23%
RARE Ultragenyx Pharmaceutical Inc.
36.14
+6.20%
JANX Janux Therapeutics, Inc.
25.01
+5.08%
VRDN Viridian Therapeutics, Inc.
13.97
+0.36%
MLTX MoonLake Immunotherapeutics
41.16
+5.51%
CYTK Cytokinetics, Incorporated
31.21
+0.61%
PTGX Protagonist Therapeutics, Inc.
50.15
+5.65%
ASND Ascendis Pharma A/S
175.69
+7.89%
SRRK Scholar Rock Holding Corporation
29.76
+2.59%